{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T10:32:08Z","timestamp":1721557928531},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,26]]},"DOI":"10.7759\/cureus.15256","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T15:36:39Z","timestamp":1622043399000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia"],"prefix":"10.7759","author":[{"given":"Quinto","family":"Gesiotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asima","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishan","family":"Avaiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30265-5","article-title":"Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands","volume":"21","author":"Dinmohamed AG","year":"2020","unstructured":"Dinmohamed AG, Visser O, Verhoeven RHA, et al.. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020, 21:750-1. 10.1016\/S1470-2045(20)30265-5","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato AR","year":"2020","unstructured":"Mato AR, Roeker LE, Lamanna N, et al.. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020, 136:1134-43. 10.1182\/blood.2020006965","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer NM","year":"2020","unstructured":"Kuderer NM, Choueiri TK, Shah DP, et al.. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020, 395:1907-18. 10.1016\/S0140-6736(20)31187-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti F","year":"2020","unstructured":"Passamonti F, Cattaneo C, Arcaini L, et al.. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020, 7:e737-45. 10.1016\/S2352-3026(20)30251-9","journal-title":"Lancet Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai M","year":"2020","unstructured":"Dai M, Liu D, Liu M, et al.. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020, 10:783-91. 10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30442-3","article-title":"COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study","volume":"21","author":"Lee LYW","year":"2020","unstructured":"Lee LYW, Cazier JB, Starkey T, et al.. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020, 21:1309-16. 10.1016\/S1470-2045(20)30442-3","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.044","article-title":"Successful outcomes of severe COVID-19 in patient with chronic lymphocytic leukemia: diagnostic challenges in immunocompromised hosts","volume":"12","author":"Malek AE","year":"2020","unstructured":"Malek AE, Gutierrez C, Mulanovich VE, et al.. Successful outcomes of severe COVID-19 in patient with chronic lymphocytic leukemia: diagnostic challenges in immunocompromised hosts. Mediterr J Hematol Infect Dis. 2020, 12:e2020044. 10.4084\/MJHID.2020.044","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30074-0","article-title":"COVID-19 in a patient with chronic lymphocytic leukaemia","volume":"7","author":"Jin XH","year":"2020","unstructured":"Jin XH, Zheng KI, Pan KH, Xie YP, Zheng MH. COVID-19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020, 7:e351-2. 10.1016\/S2352-3026(20)30074-0","journal-title":"Lancet Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00372-5","article-title":"Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality","volume":"10","author":"Mart\u00ednez-L\u00f3pez J","year":"2020","unstructured":"Mart\u00ednez-L\u00f3pez J, Mateos MV, Encinas C, et al.. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood Cancer J. 2020, 10:103. 10.1038\/s41408-020-00372-5","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00934-x","article-title":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward","volume":"13","author":"Wang B","year":"2020","unstructured":"Wang B, Van Oekelen O, Mouhieddine TH, et al.. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. J Hematol Oncol. 2020, 13:94. 10.1186\/s13045-020-00934-x","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04147-7","article-title":"COVID-19, impact on myeloma patients","volume":"99","author":"Dufour I","year":"2020","unstructured":"Dufour I, Raedemaeker J, Andreozzi F, et al.. COVID-19, impact on myeloma patients. Ann Hematol. 2020, 99:1947-9. 10.1007\/s00277-020-04147-7","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0879-9","article-title":"Multiple myeloma and COVID-19","volume":"34","author":"Dhakal B","year":"2020","unstructured":"Dhakal B, D'Souza A, Chhabra S, Hari P. Multiple myeloma and COVID-19. Leukemia. 2020, 34:1961-3. 10.1038\/s41375-020-0879-9","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16906","article-title":"A case series of monoclonal gammopathy of undetermined significance and COVID-19","volume":"190","author":"Gonzalez-Lugo JD","year":"2020","unstructured":"Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, et al.. A case series of monoclonal gammopathy of undetermined significance and COVID-19. Br J Haematol. 2020, 190:e130-3. 10.1111\/bjh.16906","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1780588","article-title":"SARS-CoV-2 in multiple myeloma: initial observation and management","volume":"61","author":"Manasanch EE","year":"2020","unstructured":"Manasanch EE, Mulanovich V, Manzano JG, et al.. SARS-CoV-2 in multiple myeloma: initial observation and management. Leuk Lymphoma. 2020, 61:2763-6. 10.1080\/10428194.2020.1780588","journal-title":"Leuk Lymphoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13502","article-title":"Outcome of COVID-19 in multiple myeloma patients in relation to treatment","volume":"105","author":"Susek KH","year":"2020","unstructured":"Susek KH, Gran C, Ljunggren HG, Alici E, Nahi H. Outcome of COVID-19 in multiple myeloma patients in relation to treatment. Eur J Haematol. 2020, 105:751-4. 10.1111\/ejh.13502","journal-title":"Eur J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10120992","article-title":"Evaluation of SARS-CoV-2 serological testing in patients with multiple myeloma and other hematologic malignancies on monoclonal antibody therapies","volume":"10","author":"Mahimainathan L","year":"2020","unstructured":"Mahimainathan L, Narasimhan M, Corchado R, et al.. Evaluation of SARS-CoV-2 serological testing in patients with multiple myeloma and other hematologic malignancies on monoclonal antibody therapies. Diagnostics (Basel). 2020, 10:992. 10.3390\/diagnostics10120992","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8840536","article-title":"COVID-19 coinfection with Mycobacterium abscessus in a patient with multiple myeloma","volume":"2021","author":"Rodriguez JA","year":"2021","unstructured":"Rodriguez JA, Bonnano C, Khatiwada P, Roa AA, Mayer D, Eckardt PA. COVID-19 coinfection with Mycobacterium abscessus in a patient with multiple myeloma. Case Rep Infect Dis. 2021, 2021:8840536. 10.1155\/2021\/8840536","journal-title":"Case Rep Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2020.12.002","article-title":"Second COVID-19 infection in a patient with multiple myeloma in Brazil - reinfection or reactivation?","volume":"43","author":"Bellesso M","year":"2021","unstructured":"Bellesso M, Bruniera FR, Trunkel AT, Nicodemo IP. Second COVID-19 infection in a patient with multiple myeloma in Brazil - reinfection or reactivation?. Hematol Transfus Cell Ther. 2021, 43:109-11. 10.1016\/j.htct.2020.12.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17168","article-title":"COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial","volume":"192","author":"Camilleri M","year":"2021","unstructured":"Camilleri M, Sive J, Wilson W, et al.. COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial. Br J Haematol. 2021, 192:e14-6. 10.1111\/bjh.17168","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd3377","article-title":"COVID-19 and cancer","volume":"368","author":"Sharpless NE","year":"2020","unstructured":"Sharpless NE. COVID-19 and cancer. Science. 2020, 368:1290. 10.1126\/science.abd3377","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30242-4","article-title":"Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care","volume":"21","author":"Jones D","year":"2020","unstructured":"Jones D, Neal RD, Duffy SRG, Scott SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 2020, 21:748-50. 10.1016\/S1470-2045(20)30242-4","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7560","article-title":"Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal [PREPRINT]","author":"Ueda M","year":"2020","unstructured":"Ueda M, Martins R, Hendrie PC, et al.. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal [PREPRINT]. J Natl Compr Canc Netw. 2020, 1-4. 10.6004\/jnccn.2020.7560","journal-title":"J Natl Compr Canc Netw"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.06.21254949","article-title":"Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients","author":"Agha M","year":"2021","unstructured":"Agha M, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients. medRxiv. 2021, 10.1101\/2021.04.06.21254949","journal-title":"medRxiv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011904","article-title":"Low neutralizing antibody responses against SARS-CoV-2 in elderly myeloma patients after the first BNT162b2 vaccine dose [PREPRINT]","author":"Terpos E","year":"2021","unstructured":"Terpos E, Trougakos IP, Gavriatopoulou M, et al.. Low neutralizing antibody responses against SARS-CoV-2 in elderly myeloma patients after the first BNT162b2 vaccine dose [PREPRINT]. Blood. 2021, 10.1182\/blood.2021011904","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60091-covid-19-virus-infection-in-three-patients-with-hypogammaglobulinemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:30Z","timestamp":1707506970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60091-covid-19-virus-infection-in-three-patients-with-hypogammaglobulinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.15256","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,26]]}}}